300 patients monitored to uncover early signs of blood cancer
NCT ID NCT04428489
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 300 people with persistent low blood cell counts (cytopenia) who do not yet have myelodysplastic syndromes (MDS), a type of blood cancer. Researchers aim to track how often these pre-MDS conditions (called ICUS and CCUS) progress to MDS. Participants receive only supportive care, and no experimental treatment is given.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could clarify which patients with early blood abnormalities are at risk of developing myelodysplastic syndromes, guiding future monitoring and treatment strategies.
What could go wrong
This is an observational study, not a treatment trial. It only tracks disease progression without testing any intervention, so it cannot directly improve patient outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China